Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,908
archived clinical trials in
Renal Impairment / Chronic Kidney Disease

Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Status: Enrolling
Updated:  9/17/2017
Hennepin County Medical Center
mi
from
Minneapolis, MN
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Status: Enrolling
Updated: 9/17/2017
Hennepin County Medical Center
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Status: Enrolling
Updated:  9/17/2017
Faireview University Medical Center
mi
from
Minneapolis, MN
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Status: Enrolling
Updated: 9/17/2017
Faireview University Medical Center
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Status: Enrolling
Updated:  9/17/2017
The Mayo Clinic
mi
from
Rochester, MN
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Status: Enrolling
Updated: 9/17/2017
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Status: Enrolling
Updated:  9/17/2017
Albany Medical Center
mi
from
Albany, NY
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Status: Enrolling
Updated: 9/17/2017
Albany Medical Center
mi
from
Albany, NY
Click here to add this to my saved trials
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Status: Enrolling
Updated:  9/17/2017
State University of New York - Downstate Medical Center
mi
from
Brooklyn, NY
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Status: Enrolling
Updated: 9/17/2017
State University of New York - Downstate Medical Center
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Status: Enrolling
Updated:  9/17/2017
Duke Univ Med Ctr
mi
from
Durham, NC
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Status: Enrolling
Updated: 9/17/2017
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Status: Enrolling
Updated:  9/17/2017
East Carolina University
mi
from
Greenville, NC
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Status: Enrolling
Updated: 9/17/2017
East Carolina University
mi
from
Greenville, NC
Click here to add this to my saved trials
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Status: Enrolling
Updated:  9/17/2017
Ohio State University Medical Center
mi
from
Columbus, OH
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Status: Enrolling
Updated: 9/17/2017
Ohio State University Medical Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Status: Enrolling
Updated:  9/17/2017
Oregon Health and Sciences University
mi
from
Portland, OR
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Status: Enrolling
Updated: 9/17/2017
Oregon Health and Sciences University
mi
from
Portland, OR
Click here to add this to my saved trials
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Status: Enrolling
Updated:  9/17/2017
Drexel University
mi
from
Philadelphia, PA
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Status: Enrolling
Updated: 9/17/2017
Drexel University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Status: Enrolling
Updated:  9/17/2017
Rhode Island Hospital
mi
from
Providence, RI
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Status: Enrolling
Updated: 9/17/2017
Rhode Island Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Status: Enrolling
Updated:  9/17/2017
University of Wisconsin-Madison
mi
from
Madison, WI
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Status: Enrolling
Updated: 9/17/2017
University of Wisconsin-Madison
mi
from
Madison, WI
Click here to add this to my saved trials
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Status: Enrolling
Updated:  9/17/2017
Medical College of Wisconsin
mi
from
Milwaukee, WI
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Status: Enrolling
Updated: 9/17/2017
Medical College of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Status: Enrolling
Updated:  9/17/2017
Universidade Federal de Sao Paulo
mi
from
Sao Paulo,
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Status: Enrolling
Updated: 9/17/2017
Universidade Federal de Sao Paulo
mi
from
Sao Paulo,
Click here to add this to my saved trials
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Status: Enrolling
Updated:  9/17/2017
Washington University
mi
from
Saint Louis, MO
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Status: Enrolling
Updated: 9/17/2017
Washington University
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Family Meeting Study for End Stage Renal Disease
Family Consultation for High-Risk Inpatients With End Stage Renal Disease: A Randomized Trial
Status: Enrolling
Updated:  9/18/2017
Henry Ford Health System
mi
from
Detroit, MI
Family Meeting Study for End Stage Renal Disease
Family Consultation for High-Risk Inpatients With End Stage Renal Disease: A Randomized Trial
Status: Enrolling
Updated: 9/18/2017
Henry Ford Health System
mi
from
Detroit, MI
Click here to add this to my saved trials
Aggrenox Prevention of Access Stenosis
Effect of Dipyridamole Plus Aspirin on Hemodialysis Graft Patency
Status: Enrolling
Updated:  9/18/2017
University of Alabama at Birmingham
mi
from
Birmingham, AL
Aggrenox Prevention of Access Stenosis
Effect of Dipyridamole Plus Aspirin on Hemodialysis Graft Patency
Status: Enrolling
Updated: 9/18/2017
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Aggrenox Prevention of Access Stenosis
Effect of Dipyridamole Plus Aspirin on Hemodialysis Graft Patency
Status: Enrolling
Updated:  9/18/2017
University of Iowa
mi
from
Iowa City, IA
Aggrenox Prevention of Access Stenosis
Effect of Dipyridamole Plus Aspirin on Hemodialysis Graft Patency
Status: Enrolling
Updated: 9/18/2017
University of Iowa
mi
from
Iowa City, IA
Click here to add this to my saved trials
Aggrenox Prevention of Access Stenosis
Effect of Dipyridamole Plus Aspirin on Hemodialysis Graft Patency
Status: Enrolling
Updated:  9/18/2017
Maine Medical Center
mi
from
Portland, ME
Aggrenox Prevention of Access Stenosis
Effect of Dipyridamole Plus Aspirin on Hemodialysis Graft Patency
Status: Enrolling
Updated: 9/18/2017
Maine Medical Center
mi
from
Portland, ME
Click here to add this to my saved trials
Aggrenox Prevention of Access Stenosis
Effect of Dipyridamole Plus Aspirin on Hemodialysis Graft Patency
Status: Enrolling
Updated:  9/18/2017
Boston University Medical Center
mi
from
Boston, MA
Aggrenox Prevention of Access Stenosis
Effect of Dipyridamole Plus Aspirin on Hemodialysis Graft Patency
Status: Enrolling
Updated: 9/18/2017
Boston University Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Aggrenox Prevention of Access Stenosis
Effect of Dipyridamole Plus Aspirin on Hemodialysis Graft Patency
Status: Enrolling
Updated:  9/18/2017
Washington University
mi
from
Saint Louis, MO
Aggrenox Prevention of Access Stenosis
Effect of Dipyridamole Plus Aspirin on Hemodialysis Graft Patency
Status: Enrolling
Updated: 9/18/2017
Washington University
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Aggrenox Prevention of Access Stenosis
Effect of Dipyridamole Plus Aspirin on Hemodialysis Graft Patency
Status: Enrolling
Updated:  9/18/2017
Duke Univ Med Ctr
mi
from
Durham, NC
Aggrenox Prevention of Access Stenosis
Effect of Dipyridamole Plus Aspirin on Hemodialysis Graft Patency
Status: Enrolling
Updated: 9/18/2017
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Aggrenox Prevention of Access Stenosis
Effect of Dipyridamole Plus Aspirin on Hemodialysis Graft Patency
Status: Enrolling
Updated:  9/18/2017
Wake Forest University
mi
from
Winston-Salem, NC
Aggrenox Prevention of Access Stenosis
Effect of Dipyridamole Plus Aspirin on Hemodialysis Graft Patency
Status: Enrolling
Updated: 9/18/2017
Wake Forest University
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Aggrenox Prevention of Access Stenosis
Effect of Dipyridamole Plus Aspirin on Hemodialysis Graft Patency
Status: Enrolling
Updated:  9/18/2017
Vanderbilt University
mi
from
Nashville, TN
Aggrenox Prevention of Access Stenosis
Effect of Dipyridamole Plus Aspirin on Hemodialysis Graft Patency
Status: Enrolling
Updated: 9/18/2017
Vanderbilt University
mi
from
Nashville, TN
Click here to add this to my saved trials
Aggrenox Prevention of Access Stenosis
Effect of Dipyridamole Plus Aspirin on Hemodialysis Graft Patency
Status: Enrolling
Updated:  9/18/2017
University of Texas Southwestern
mi
from
Dallas, TX
Aggrenox Prevention of Access Stenosis
Effect of Dipyridamole Plus Aspirin on Hemodialysis Graft Patency
Status: Enrolling
Updated: 9/18/2017
University of Texas Southwestern
mi
from
Dallas, TX
Click here to add this to my saved trials
The Pharmacokinetics of Gefapixant (MK-7264) in Participants With Renal Insufficiency (MK-7264-026)
An Open-Label, Single-Dose Study to Investigate the Influence of Renal Insufficiency on the Pharmacokinetics of MK-7264
Status: Enrolling
Updated:  9/19/2017
Clinical Pharmacology of Miami, Inc.
mi
from
Hialeah, FL
The Pharmacokinetics of Gefapixant (MK-7264) in Participants With Renal Insufficiency (MK-7264-026)
An Open-Label, Single-Dose Study to Investigate the Influence of Renal Insufficiency on the Pharmacokinetics of MK-7264
Status: Enrolling
Updated: 9/19/2017
Clinical Pharmacology of Miami, Inc.
mi
from
Hialeah, FL
Click here to add this to my saved trials
The Pharmacokinetics of Gefapixant (MK-7264) in Participants With Renal Insufficiency (MK-7264-026)
An Open-Label, Single-Dose Study to Investigate the Influence of Renal Insufficiency on the Pharmacokinetics of MK-7264
Status: Enrolling
Updated:  9/19/2017
Orlando Clinical Research Center
mi
from
Orlando, FL
The Pharmacokinetics of Gefapixant (MK-7264) in Participants With Renal Insufficiency (MK-7264-026)
An Open-Label, Single-Dose Study to Investigate the Influence of Renal Insufficiency on the Pharmacokinetics of MK-7264
Status: Enrolling
Updated: 9/19/2017
Orlando Clinical Research Center
mi
from
Orlando, FL
Click here to add this to my saved trials
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects With Stage III to V Chronic Kidney Disease Not on Dialysis
Status: Enrolling
Updated:  9/20/2017
Clinical Research Facility
mi
from
Tempe, AZ
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects With Stage III to V Chronic Kidney Disease Not on Dialysis
Status: Enrolling
Updated: 9/20/2017
Clinical Research Facility
mi
from
Tempe, AZ
Click here to add this to my saved trials
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects With Stage III to V Chronic Kidney Disease Not on Dialysis
Status: Enrolling
Updated:  9/20/2017
Clinical Research Facility
mi
from
La Mesa, CA
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects With Stage III to V Chronic Kidney Disease Not on Dialysis
Status: Enrolling
Updated: 9/20/2017
Clinical Research Facility
mi
from
La Mesa, CA
Click here to add this to my saved trials
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects With Stage III to V Chronic Kidney Disease Not on Dialysis
Status: Enrolling
Updated:  9/20/2017
Clinical Research Facility
mi
from
Sacramento, CA
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects With Stage III to V Chronic Kidney Disease Not on Dialysis
Status: Enrolling
Updated: 9/20/2017
Clinical Research Facility
mi
from
Sacramento, CA
Click here to add this to my saved trials
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects With Stage III to V Chronic Kidney Disease Not on Dialysis
Status: Enrolling
Updated:  9/20/2017
Clinical Research Facility
mi
from
Denver, CO
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects With Stage III to V Chronic Kidney Disease Not on Dialysis
Status: Enrolling
Updated: 9/20/2017
Clinical Research Facility
mi
from
Denver, CO
Click here to add this to my saved trials
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects With Stage III to V Chronic Kidney Disease Not on Dialysis
Status: Enrolling
Updated:  9/20/2017
Clinical Research Facility
mi
from
Edgewater, FL
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects With Stage III to V Chronic Kidney Disease Not on Dialysis
Status: Enrolling
Updated: 9/20/2017
Clinical Research Facility
mi
from
Edgewater, FL
Click here to add this to my saved trials
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects With Stage III to V Chronic Kidney Disease Not on Dialysis
Status: Enrolling
Updated:  9/20/2017
Clinical Research Facility
mi
from
Miami, FL
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects With Stage III to V Chronic Kidney Disease Not on Dialysis
Status: Enrolling
Updated: 9/20/2017
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects With Stage III to V Chronic Kidney Disease Not on Dialysis
Status: Enrolling
Updated:  9/20/2017
Clinical Research Facility
mi
from
Meridian, ID
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects With Stage III to V Chronic Kidney Disease Not on Dialysis
Status: Enrolling
Updated: 9/20/2017
Clinical Research Facility
mi
from
Meridian, ID
Click here to add this to my saved trials
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects With Stage III to V Chronic Kidney Disease Not on Dialysis
Status: Enrolling
Updated:  9/20/2017
Clinical Research Facility
mi
from
Evergreen Park, IL
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects With Stage III to V Chronic Kidney Disease Not on Dialysis
Status: Enrolling
Updated: 9/20/2017
Clinical Research Facility
mi
from
Evergreen Park, IL
Click here to add this to my saved trials
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects With Stage III to V Chronic Kidney Disease Not on Dialysis
Status: Enrolling
Updated:  9/20/2017
Clinical Research Facility
mi
from
Bethesda, MD
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects With Stage III to V Chronic Kidney Disease Not on Dialysis
Status: Enrolling
Updated: 9/20/2017
Clinical Research Facility
mi
from
Bethesda, MD
Click here to add this to my saved trials
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects With Stage III to V Chronic Kidney Disease Not on Dialysis
Status: Enrolling
Updated:  9/20/2017
Clinical Research Facility
mi
from
Springfield, MA
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects With Stage III to V Chronic Kidney Disease Not on Dialysis
Status: Enrolling
Updated: 9/20/2017
Clinical Research Facility
mi
from
Springfield, MA
Click here to add this to my saved trials
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects With Stage III to V Chronic Kidney Disease Not on Dialysis
Status: Enrolling
Updated:  9/20/2017
Clinical Research Facility
mi
from
Detroit, MI
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects With Stage III to V Chronic Kidney Disease Not on Dialysis
Status: Enrolling
Updated: 9/20/2017
Clinical Research Facility
mi
from
Detroit, MI
Click here to add this to my saved trials
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects With Stage III to V Chronic Kidney Disease Not on Dialysis
Status: Enrolling
Updated:  9/20/2017
Clinical Research Facility
mi
from
Pontiac, MI
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects With Stage III to V Chronic Kidney Disease Not on Dialysis
Status: Enrolling
Updated: 9/20/2017
Clinical Research Facility
mi
from
Pontiac, MI
Click here to add this to my saved trials
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects With Stage III to V Chronic Kidney Disease Not on Dialysis
Status: Enrolling
Updated:  9/20/2017
Clinical Research Facility
mi
from
Reno, NV
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects With Stage III to V Chronic Kidney Disease Not on Dialysis
Status: Enrolling
Updated: 9/20/2017
Clinical Research Facility
mi
from
Reno, NV
Click here to add this to my saved trials
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects With Stage III to V Chronic Kidney Disease Not on Dialysis
Status: Enrolling
Updated:  9/20/2017
Clinical Research Facility
mi
from
Great Neck, NY
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects With Stage III to V Chronic Kidney Disease Not on Dialysis
Status: Enrolling
Updated: 9/20/2017
Clinical Research Facility
mi
from
Great Neck, NY
Click here to add this to my saved trials
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects With Stage III to V Chronic Kidney Disease Not on Dialysis
Status: Enrolling
Updated:  9/20/2017
Clinical Research Facility
mi
from
Mineola, NY
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects With Stage III to V Chronic Kidney Disease Not on Dialysis
Status: Enrolling
Updated: 9/20/2017
Clinical Research Facility
mi
from
Mineola, NY
Click here to add this to my saved trials
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects With Stage III to V Chronic Kidney Disease Not on Dialysis
Status: Enrolling
Updated:  9/20/2017
Clinical Research Facility
mi
from
Asheville, NC
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects With Stage III to V Chronic Kidney Disease Not on Dialysis
Status: Enrolling
Updated: 9/20/2017
Clinical Research Facility
mi
from
Asheville, NC
Click here to add this to my saved trials
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects With Stage III to V Chronic Kidney Disease Not on Dialysis
Status: Enrolling
Updated:  9/20/2017
Clinical Research Facility
mi
from
Wilmington, NC
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects With Stage III to V Chronic Kidney Disease Not on Dialysis
Status: Enrolling
Updated: 9/20/2017
Clinical Research Facility
mi
from
Wilmington, NC
Click here to add this to my saved trials
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects With Stage III to V Chronic Kidney Disease Not on Dialysis
Status: Enrolling
Updated:  9/20/2017
Clinical Research Facility
mi
from
Orangeburg, SC
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects With Stage III to V Chronic Kidney Disease Not on Dialysis
Status: Enrolling
Updated: 9/20/2017
Clinical Research Facility
mi
from
Orangeburg, SC
Click here to add this to my saved trials
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects With Stage III to V Chronic Kidney Disease Not on Dialysis
Status: Enrolling
Updated:  9/20/2017
Clinical Research Facility
mi
from
Houston, TX
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects With Stage III to V Chronic Kidney Disease Not on Dialysis
Status: Enrolling
Updated: 9/20/2017
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects With Stage III to V Chronic Kidney Disease Not on Dialysis
Status: Enrolling
Updated:  9/20/2017
Clinical Research Facility
mi
from
San Antonio, TX
Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis
A Phase 2 Study of KRX-0502 (Ferric Citrate) in Managing Serum Phosphorus and Iron Deficiency in Anemic Subjects With Stage III to V Chronic Kidney Disease Not on Dialysis
Status: Enrolling
Updated: 9/20/2017
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Ultrasound Instrument to Prevent Dialysis Graft Failure
New Doppler Instrument for Preventing Impending Access-Graft Failure Randomized Trial
Status: Enrolling
Updated:  9/26/2017
Queens Artificial Kidney Center
mi
from
Jackson Heights, NY
Ultrasound Instrument to Prevent Dialysis Graft Failure
New Doppler Instrument for Preventing Impending Access-Graft Failure Randomized Trial
Status: Enrolling
Updated: 9/26/2017
Queens Artificial Kidney Center
mi
from
Jackson Heights, NY
Click here to add this to my saved trials
Ultrasound Instrument to Prevent Dialysis Graft Failure
New Doppler Instrument for Preventing Impending Access-Graft Failure Randomized Trial
Status: Enrolling
Updated:  9/26/2017
St Albans Dialysis Center
mi
from
Jamaica, NY
Ultrasound Instrument to Prevent Dialysis Graft Failure
New Doppler Instrument for Preventing Impending Access-Graft Failure Randomized Trial
Status: Enrolling
Updated: 9/26/2017
St Albans Dialysis Center
mi
from
Jamaica, NY
Click here to add this to my saved trials
A Trial of Ferumoxytol for the Treatment of Iron Deficiency Anemia in Pediatric Participants With Chronic Kidney Disease
A Randomized, Open-Label, Active-Controlled Study of the Safety, Efficacy, and Pharmacokinetics of Ferumoxytol Compared With Oral Iron for the Treatment of Iron Deficiency Anemia in Pediatric Subjects With Chronic Kidney Disease
Status: Enrolling
Updated:  10/3/2017
AMAG Pharmaceuticals, Inc.
mi
from
Waltham, MA
A Trial of Ferumoxytol for the Treatment of Iron Deficiency Anemia in Pediatric Participants With Chronic Kidney Disease
A Randomized, Open-Label, Active-Controlled Study of the Safety, Efficacy, and Pharmacokinetics of Ferumoxytol Compared With Oral Iron for the Treatment of Iron Deficiency Anemia in Pediatric Subjects With Chronic Kidney Disease
Status: Enrolling
Updated: 10/3/2017
AMAG Pharmaceuticals, Inc.
mi
from
Waltham, MA
Click here to add this to my saved trials